Sucampo Pharmaceuticals, Inc. (SCMP) Reports Q3 Loss of $0.10, Sales Miss Expectations
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Income (loss) before income taxes: 15.5M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income (loss) before income taxes: 15.5M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) reported Q3 EPS of ($0.10), versus $0.05 reported last year. Revenue for the quarter came in at $14.37 million, versus $20.9 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
